The diseases listed in this rule and classified as "Class A", "Class B", and "Class C" are declared to be dangerous to the public health and are reportable. The occurrence of cases or suspected cases of a disease classified as "Class A", "Class B", or "Class C" shall be reported to the board of health on forms as prescribed and provided by the director and shall be reported in accordance with this rule and Chapter 3701-3 of the Administrative Code.

(A) The following diseases are classified as "Class A":

(1) Diseases of major public health concern because of the severity of disease or potential for epidemic spread:

(a) Anthrax

(b) Botulism, foodborne;

(c) Cholera;

(d) Diphtheria;

(e) Measles;

(f) Meningococcal disease;

(g) Plague;

(h) Rabies, human;

(i) Rubella (not congenital);

(2) Diseases of public health concern needing timely response because of potential for epidemic spread:

(a) Chancroid;

(b) Cyclosporiasis;

(c) Dengue;

(d) E. Coli O157:H7;

(e) Encephalitis, including arthropod-borne;

(f) Foodborne disease outbreaks;

(g) Granuloma inguinale;

(h) Haemophilus influenzae (invasive disease);

(i) Hantavirus;

(j) Hemolytic uremic syndrome;

(k) Hepatitis A;

(l) Legionnaires' disease;

(m) Listeriosis;

(n) Malaria;

(o) Meningitis, aseptic, including lymphocytic choriomeningitis and viral meningoencephalitis;

(p) Mumps;

(q) Mycobacterial disease, including tuberculosis;

(r) Pertussis;

(s) Poliomyelitis (including vaccine-associated cases);

(t) Psittacosis;

(u) Rubella, congenital;

(v) Salmonellosis;

(w) Shigellosis;

(x) Syphilis;

(y) Tetanus;

(z) Typhoid fever;

(aa) Waterborne disease outbreaks;

(bb) Yellow fever.

(3) Diseases of significant public health concern:

(a) Amebiasis;

(b) Botulism;

(i) Wound;

(ii) Infant;

(c) Brucellosis;

(d) Campylobacteriosis;

(e) Chlamydia infections (nonspecific urethritis, cervicitis, salpingitis, neonatal conjunctivitis, pneumonia, and lymphogranuloma venereum);

(f) Creutzfeldt-Jakob disease;

(g) Cryptosporidiosis;

(h) Cytomegalovirus (congenital only);

(i) Encephalitis

(i) Other viral;

(ii) Post-infection;

(j) Giardiasis;

(k) Gonococcal infections;

(l) Hepatitis B, C, and non-A, non-B;

(m) Herpes (congenital only);

(n) Leprosy;

(o) Leptospirosis;

(p) Lyme disease;

(q) Meningitis, including other bacterial;

(r) Mucocutaneous lymph node syndrome (Kawasaki disease);

(s) Pelvic inflammatory disease, gonococcal;

(t) Streptococcus pneumoniae, invasive disease;

(u) Reye syndrome;

(v) Rheumatic fever;

(w) Rocky mountain spotted fever;

(x) Streptococcal disease, group A, invasive;

(y) Streptococcal Bin newborn;

(z) Streptococcal toxic shock syndrome;

(aa) Toxic shock syndrome (T.S.S.);

(bb) Toxoplasmosis (congenital);

(cc) Trichinosis;

(dd) Tularemia;

(ee) Typhus fever;

(ff) Vancomycin resistant enterococcus;

(gg) Vibriosis; and

(hh) Yersiniosis.

(B) The following diseases are classified as "Class B":

(1) Chickenpox;

(2) Herpes-genital; and

(3) Influenza.

(C) The following diseases are classified as "Class C":

(1) Blastomycosis;

(2) Conjunctivitis, acute;

(3) Histoplasmosis;

(4) Nosocomial infections of any type;

(5) Pediculosis;

(6) Scabies;

(7) Sporotrichosis;

(8) Staphylococcal skin infections; and

(9) Toxoplasmosis.

HISTORY: Eff 7-23-98; 1-1-99
Rule promulgated under: RC Chapter 119 .
Rule authorized by: RC 3701.13 , 3701.24 , 3701.34 , 3707.06
Rule amplifies: RC 3701.24 , 3707.06 R.C. 119.032 review date: 7/23/03